ABCB 1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

ABCB 1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy

Published:2014-12-08 Issue:1 Volume:106 Page:86-93
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Kim Hee‐Jun¹,Im Seock‐Ah²³,Keam Bhumsuk²³,Ham Hye Seon³,Lee Kyung Hun²³,Kim Tae Yong²³,Kim Yu Jung³⁴,Oh Do‐Youn²³,Kim Jee Hyun²³⁴,Han Wonshik³⁵,Jang In‐Jin⁶,Kim Tae‐You²³,Park In Ae⁷,Noh Dong Young³⁵

Affiliation:

1. Department of Internal Medicine Chung‐Ang University College of Medicine SeoulKorea

2. Department of Internal Medicine Seoul National University College of Medicine SeoulKorea

3. Cancer Research Institute Seoul National University SeoulKorea

4. Department of Internal Medicine Seoul National University Bundang Hospital SeongnamKorea

5. Department of Surgery Seoul National University College of Medicine SeoulKorea

6. Department of Clinical Pharmacology Seoul National University College of Medicine SeoulKorea

7. Department of Pathology Seoul National University College of Medicine Seoul Korea

Funder

the Ministry of Education

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12560

Reference39 articles.

1. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

2. Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27

3. Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapy

4. Incidence and Impact of Documented Eradication of Breast Cancer Axillary Lymph Node Metastases Before Surgery in Patients Treated With Neoadjuvant Chemotherapy

5. Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer.

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GSTM1 Deletion Compensated in mRNA Expression and 4T1 Viability After Editing Using CRISPR/Cas9 Single and Double gRNA;The Indonesian Biomedical Journal;2023-04-18

2. A meta-analysis and experimental data for multidrug resistance genes in breast cancer;African Health Sciences;2022-12-21

3. Impact of ABCB1 , ABCC1 , ABCC2 , and ABCG2 variants in predicting prognosis and clinical outcomes of north Indian lung cancer patients undergoing platinum‐based doublet chemotherapy;The Journal of Gene Medicine;2022-11-14

4. Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy;Cancers;2022-11-04

5. Immunohistochemical expression of PD-L1 and MDR1 in breast tumors: association with clinico-pathological parameters and treatment outcome;Clinical and Experimental Medicine;2022-07-09